Compare CSTL & CWCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSTL | CWCO |
|---|---|---|
| Founded | 2007 | 1973 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 611.1M | 514.1M |
| IPO Year | 2019 | 1997 |
| Metric | CSTL | CWCO |
|---|---|---|
| Price | $21.05 | $30.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $45.50 | $40.00 |
| AVG Volume (30 Days) | ★ 468.8K | 83.3K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $344,229,000.00 | $132,073,368.00 |
| Revenue This Year | $2.42 | $4.34 |
| Revenue Next Year | $12.69 | $42.86 |
| P/E Ratio | ★ N/A | $131.15 |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $14.59 | $26.71 |
| 52 Week High | $44.28 | $39.12 |
| Indicator | CSTL | CWCO |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 41.88 |
| Support Level | $17.72 | $30.09 |
| Resistance Level | $24.46 | $34.26 |
| Average True Range (ATR) | 1.12 | 0.88 |
| MACD | 0.37 | 0.13 |
| Stochastic Oscillator | 74.65 | 37.17 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.